{
  "id": "601ff4a61cb411341a000076",
  "type": "factoid",
  "question": "What class of drugs frequently has muscle pain and other muscle toxicities such as mysositis and rhabdomyolysis as a side effect?",
  "ideal_answer": " Muscular complaints are known side-effects of statin therapy, ranging from myalgia to clinically important myositis and rhabdomyolysis.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/17143099",
    "http://www.ncbi.nlm.nih.gov/pubmed/19940267",
    "http://www.ncbi.nlm.nih.gov/pubmed/20195425",
    "http://www.ncbi.nlm.nih.gov/pubmed/26402985",
    "http://www.ncbi.nlm.nih.gov/pubmed/27870723",
    "http://www.ncbi.nlm.nih.gov/pubmed/33194498",
    "http://www.ncbi.nlm.nih.gov/pubmed/15269925",
    "http://www.ncbi.nlm.nih.gov/pubmed/17700359",
    "http://www.ncbi.nlm.nih.gov/pubmed/12426921",
    "http://www.ncbi.nlm.nih.gov/pubmed/16575599",
    "http://www.ncbi.nlm.nih.gov/pubmed/15849374",
    "http://www.ncbi.nlm.nih.gov/pubmed/11869826"
  ],
  "snippets": [
    {
      "text": "3-hydroxy-3-methylglutaryl coenzyme A reductase reductase inhibitors (statins) are generally well tolerated, with statin-associated muscle symptoms (SAMS) the most common side effect (~10%) seen in statin users.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27870723",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Muscular complaints are known side-effects of statin therapy, ranging from myalgia to clinically important myositis and rhabdomyolysis. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26402985",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " the statin use and association with the presence and characteristics of muscular complaints.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26402985",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "n the studied set of patients muscular symptoms were a rather frequent effect of statin therapy. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26402985",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "yopathy is included among the potential side-effects and toxicities associated with the lipid lowering agents, particularly 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. However, the precise mechanism of statin-induced muscle toxicity remains unclear.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15849374",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Lipid lowering drugs, such as statins, are commonly used to treat approximately 10 million Canadians affected by hypercholesterolemia. The most commonly experienced side-effect of statin medication is muscle pain",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20195425",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Statin induced myopathy consists of a spectrum of myopathic disorders ranging from mild myalgia to fatal rhabdomyolysis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20195425",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " The following is a presentation of 2 cases of statin induced myopathy in patients ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20195425",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In addition, discussion will surround the mechanism, predisposing risk factors and frequency of statin induced myopathy",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20195425",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Rhabdomyolysis is a known, rare serious side effect of statin monotherapy and of statin-fibrate combination therapy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15269925",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Statin use is associated with a variety of overtly related muscle symptoms including muscle pain, myalgia, creatine kinase elevations without pain with myolysis and myositis (rhabdomyolysis), a potentially fatal side effect that led to the withdrawal of cerivastatin in 2001.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17700359",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CYP2D6*4 polymorphism is associated with statin-induced muscle effects.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17700359",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Although statins are well tolerated, many patients develop myopathy manifesting as muscle aches and pain.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19940267",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Rhabdomyolysis is a rare but severe toxicity of statins.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19940267",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The drugs which most frequently induce muscular side effects are steroids, statins, fibrates, antiretrovirals, immunosuppressants, colchicine, amiodarone, and anticancer drugs.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16575599",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Muscular side effects of various anesthetics, analgetics, antibiotics, antihistaminic drugs, antiretrovirals, cardiotropics, immunosuppressants, lipid-lowering drugs, psychotropic drugs, anticancer drugs, and other substances are more frequent than assumed and are easily overlooked.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16575599",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Muscle pain is a frequent adverse effect of statins.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33194498",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Myopathy and rhabdomyolysis with lipid-lowering drugs.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11869826",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "PURPOSE OF REVIEW: Lipid-lowering drugs are associated with myotoxicity, which ranges in severity from myalgias to rhabdomyolysis resulting in renal",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17143099",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Myopathy caused by HMG-CoA reductase inhibitors (statins) alone is rare, but occurs more frequently when a statin is used with gemfibrozil, a medication that likely has a direct toxic effect on muscles.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12426921",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Myotoxicity associated with lipid-lowering drugs.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17143099",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12426921",
      "beginSection": "title",
      "endSection": "title"
    }
  ],
  "concepts": [],
  "exact_answer": "statins"
}